Reduced-energy diet improves survival of obese KKAy mice with viral myocarditis: Induction of cardiac adiponectin expression

International Journal of Cardiology

Volumn 119, Issue 3, 2007, Pages 310-318

  Kanda, Tsugiyasu ^a   Saegusa, Seiichiro ^a   Takahashi, Takashi ^a   Sumino, Hiroyuki ^b   Morimoto, Shigeto ^a   Nakahashi, Takeshi ^a   Iwai, Kunimitsu ^a   Matsumoto, Masayuki ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; Food restriction; Myocarditis; Obesity

Indexed keywords

ADIPONECTIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; HEART MUSCLE; HEART PROTECTION; HEART WEIGHT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; UPREGULATION; VIRUS MYOCARDITIS; WEIGHT REDUCTION;

ADIPONECTIN; ANIMALS; CALORIC RESTRICTION; CARDIOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; MICE; MICE, OBESE; MYOCARDITIS; OBESITY; RNA, MESSENGER; SURVIVAL ANALYSIS; WEIGHT LOSS;

EID: 34250302749     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.07.181     Document Type: Article

References (37)

1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The Evidence Report. National Institutes of Health. Obes Res 6 (1998) 51S-209S
2. Sjostrom C.D., Lissner L., Wedel H., and Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 7 (1999) 477-484
3. Alpert M.A., Terry B.E., and Kelly D.L. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol 55 (1985) 783-786
4. Klein S., Burke L.E., Bray G.A., et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 110 (2004) 2952-2967
5. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
6. Lihn A.S., Sterged T., Nyholm B., Pedersen S.B., Richelsen B., and Schmitz O. Adiponectin mRNA expression in subcutaneous adipose tissue is reduced in first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 284 (2003) E443-E448
7. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
8. Matsuzawa Y. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract 3 (2006) 35-42
9. Yang W.S., Lee W.S., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
10. Kanda T., McManus J.E., Yang D.C., et al. Modification of viral myocarditis in mice by interleukin-6. Circ Res 78 (1996) 848-858
11. Kwon K., Jung S.H., Choi C., and Park S.H. Reciprocal association between visceral obesity and adiponectin: in healthy menopausal women. Int J Cardiol 101 (2005) 385-390
12. Ajuwon K.M., and Spurlock M.E. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 288 (2005) R1220-R1225
13. Lamas O., Moreno-Aliaga M.J., Martinez J.A., and Marti A. NF-kappa B-binding activity in an animal diet-induced overweightness model and the impact of subsequent energy restriction. Biochem Biophys Res Commun 311 (2003) 533-539
14. Contaldo F., Pasanisi F., Finelli C., and de Simone G. Obesity, heart failure and sudden death. Nutr Metab Cardiovasc Dis 12 (2002) 190-197
15. Shibata R., Ouchi N., Ito M., et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10 (2004) 1384-1389
16. Milan G., Granzotto M., Scarda A., et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 11 (2002) 1095-1103
17. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271 (1996) 10697-10703
18. Berg A.H., Combs T.P., Du X., Brownlee M., and Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7 (2001) 947-953
19. Eyre H., Kahn R., Robertson R.M., et al. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation 109 (2004) 3244-3255
20. Curtis J.P., Selter J.G., Wang Y., et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165 (2005) 55-61
21. Ishikawa Y., Akasaka Y., Ishii T., et al. Changes in the distribution pattern of gelatin-binding protein of 28 kDa (adiponectin) in myocardial remodelling after ischaemic injury. Histopathology 42 (2003) 43-52
22. Takahashi T., Saegusa S., Sumino H., et al. Adiponectin, T-cadherin and tumor necrosis factor-alpha in damaged cardiomyocytes from autopsy specimens. J Int Med Res 33 (2005) 236-244
23. Takano H., Nagai T., Asakawa M., et al. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes. Circ Res 87 (2000) 596-602
24. Vidal-Puig A.J., Considine R.V., Jimenez-Linan M., et al. Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99 (1997) 2416-2422
25. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
26. Skolnik P.R., Rabbi M.F., Mathys J.M., and Greenberg A.S. Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNF alpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects. J Acquir Immune Defic Syndr 31 (2002) 1-10
27. Hiscott J., Kwon H., and Gein P. Hostile takeovers: viral appropriation of the NF-κB pathway. J Clin Invest 107 (2001) 143-151
28. Purcell N.H., Tang G., Yu C., Mercurio F., diDonato J.A., and Lin A. Activation of NF-kB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A 98 (2001) 6668-6673
29. Nieman D.C., Henson D.A., Nehlsen-Cannarella S.L., et al. Influence of obesity on immune function. J Am Diet Assoc 99 (1999) 244-249
30. Lamas O., Martinez J.A., and Marti A. Energy restriction restores the impaired immune response in overweight (cafeteria) rats. J Nutr Biochem 15 (2004) 418-425
31. Klein S., Fontana L., Young V.L., et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350 (2004) 2549-2557
32. Kapadia S.R., Oral H., Lee J., Nakano M., Taffet G.E., and Mann D.L. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 81 (1997) 187-195
33. Sun M., Dawood F., Wen W.H., et al. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 110 (2004) 3221-3228
34. Yue P., Massie B.M., Simpson P.C., and Long C.S. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol 275 (1998) H250-H258
35. Yokoyama T., Vaca L., Rossen R.D., Durante W., Hazarika P., and Mann D.L. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92 (1993) 2303-2312
36. Maeda N., Shimomura I., Kishida K., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8 (2002) 731-737
37. Lihn A.S., Richelsen B., Pedersen S.B., et al. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab 285 (2003) E1072-E1080